0001171843-16-013622.txt : 20161213 0001171843-16-013622.hdr.sgml : 20161213 20161213165707 ACCESSION NUMBER: 0001171843-16-013622 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161212 FILED AS OF DATE: 20161213 DATE AS OF CHANGE: 20161213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001582313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980661854 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W BUSINESS PHONE: (604) 484-3300 MAIL ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TARNOW MICHAEL M CENTRAL INDEX KEY: 0001263647 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36687 FILM NUMBER: 162049545 4 1 formfour.xml OWNERSHIP DOCUMENT X0306 4 2016-12-12 0 0001582313 Xenon Pharmaceuticals Inc. XENE 0001263647 TARNOW MICHAEL M C/O XENON PHARMACEUTICALS INC 200 - 3650 GILMORE WAY BURNABY A1 V5G 4W8 BRITISH COLUMBIA, CANADA 1 0 0 0 Common Shares 2016-12-12 4 M 0 14403 3.21 A 69570 D Common Shares 2016-12-12 5 G 0 E 7202 0.00 D 62368 D Stock Option (Right to Buy) 3.21 2016-12-12 4 M 0 14403 0.00 D 2016-12-31 Common Shares 14403 0 D The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. The shares were gifted to family members that do not share the reporting person's household. The shares subject to the option fully vested on December 31, 2009. /s/ Joanne Smartt, Attorney-in-fact 2016-12-13